Razorpay Clears SEBI Review for IPO Reported at Up to 6,000 Crore Rupees

India's market regulator has cleared Razorpay's initial public offering, with the deal reported at 5,000 crore to 6,000 crore rupees, or roughly $560 million to $680 million. The Securities and Exchange Board of India (SEBI) issued its final observations on Razorpay's draft papers on Nov. 3, according to the regulator's update reported on Nov. 13. The same update cleared Sembcorp Green Infra and MakeMyTrip India, and the Razorpay approval was first reported on Nov. 4, citing people familiar with the matter.

Razorpay itself has not disclosed the issue size. The 5,000-6,000 crore rupee figure comes from PTI, citing people familiar with the matter. Media reports put the targeted valuation at about $5 billion — a third below the $7.5 billion valuation of Razorpay's 2021 funding round. In plain terms, the company is coming to market at a materially lower price than its last private mark.

What does the approval actually unlock?

Razorpay pre-filed its draft prospectus in June through SEBI's confidential route, which keeps detailed financials private during the review. The Nov. 3 observations start a defined clock.

The company must now publish an updated draft prospectus and leave it open for at least 21 days of public comment. Only then can it file a red herring prospectus with a price band. It has 18 months from SEBI's observations to open the offer.

Reports say the deal will combine new shares with a sale by existing investors. Shareholders approved a fresh issue of up to 2,700 crore rupees in May. Axis Capital, Kotak Mahindra Capital, JPMorgan and Citi are the bankers.

A listing is most likely between January and March 2027, though the offer could open as early as December. The takeaway: regulatory clearance is done, but the pricing and timing decisions still sit ahead.

Who is selling, and to whom?

Harshil Mathur and Shashank Kumar founded Razorpay in 2014. The company sells payment processing, business banking, payouts, payroll and lending to customers ranging from startups to large corporates.

Its investor list includes:

• Peak XV Partners
• GIC
• Tiger Global
• Ribbit Capital
• Lone Pine Capital
• Alkeon Capital
• TCV

Roughly a fifth of the reported deal size — the 2,700 crore rupee fresh issue approved in May — would flow into the company itself, with the balance returning to early backers through the secondary component.

What do the numbers show?

Consolidated revenue rose 65% to 3,783 crore rupees in the year to March 2025. Growth at that pace gives the company a growth story to sell into the listing window.

Profitability is murkier. A one-time hit from employee stock options, restructuring and taxes on moving its parent company from the US to India produced a post-ESOP loss of 1,209 crore rupees. That reverse flip, completed in 2025, cost about $150 million in taxes, and it was a precondition for listing in India rather than abroad.

The mechanism matters here: Indian listings require an Indian parent, so the roughly $150 million tax bill was effectively the price of admission to the domestic market. The loss it helped create lands in the same financial year investors will scrutinize in the updated draft prospectus.

Why the valuation gap matters

The reported $5 billion target sits against the $7.5 billion valuation set in 2021, when private money was cheapest. A haircut of that size signals that Razorpay and its bankers expect public investors to apply harder discipline than late-stage venture funds did.

The 21-day public comment period and the eventual red herring prospectus will show whether the fresh issue stays at the approved 2,700 crore rupees or moves higher. If the December opening materializes, Razorpay would reach the market well before the January-March 2027 window that most reports consider the base case — and set an early pricing reference for the other Indian fintech issuers queuing behind it.